Ukrainian President Volodymyr Zelenskiy has called for a direct meeting with U.S. President Donald Trump to resolve the most sensitive elements of a potential peace agreement with Russia, particularly issues related to territorial control. His remarks came after the latest round of U.S.-Ukrainian talks, signaling cautious progress toward ending the war that began with Russia’s full-scale invasion in 2022.
Speaking to reporters in comments released by his office on Wednesday, Zelenskiy said Ukrainian and U.S. delegations had moved closer to finalizing a 20-point framework during talks held over the weekend in Miami. He described the document as a foundational political framework involving Ukraine, the United States, Europe, and Russia, aimed at ending the conflict. According to Zelenskiy, while technical and security matters can be discussed at lower levels, questions of territory must be decided by national leaders.
The push for renewed diplomacy comes as Trump continues to state his desire to end what he has called Europe’s deadliest war since World War Two. However, Kyiv has expressed concerns over earlier U.S.-backed peace drafts that appeared to align with Moscow’s demands, including territorial concessions, limits on Ukraine’s armed forces, and a commitment to avoid future military alliances. Ukrainian officials argue such terms would leave the country vulnerable to renewed Russian aggression.
Zelenskiy noted that the new 20-point framework represents a significant evolution from an earlier 28-point proposal discussed primarily between the United States and Russia. Under the updated framework, Ukraine would maintain its armed forces at their current level of roughly 800,000 troops. Additional agreements with the United States and European partners would provide what Zelenskiy described as strong and enforceable security guarantees, including mechanisms to monitor compliance and respond to any renewed Russian attacks.
The talks also addressed post-war reconstruction and investment, highlighting the economic dimension of any future peace deal. Despite progress, major disagreements remain unresolved. Zelenskiy said Ukraine’s position is to freeze the conflict along current front lines, while Russia is demanding that Ukrainian forces withdraw from the entire Donetsk region, where Moscow controls most but not all territory.
The status of the Russian-occupied Zaporizhzhia nuclear power plant also remains undecided. Zelenskiy said Kyiv has proposed creating a small economic zone around the site. The 20-point proposal will now be reviewed by Moscow, after which the next steps in the peace process will be determined.


Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Trump Rejects Putin’s New START Extension Offer, Raising Fears of a New Nuclear Arms Race
Trump Allegedly Sought Airport, Penn Station Renaming in Exchange for Hudson River Tunnel Funding
Trump Says “Very Good Talks” Underway on Russia-Ukraine War as Peace Efforts Continue
Ohio Man Indicted for Alleged Threat Against Vice President JD Vance, Faces Additional Federal Charges
U.S. Sanctions on Russia Could Expand as Ukraine Peace Talks Continue, Says Treasury Secretary Bessent
Marco Rubio Steps Down as Acting U.S. Archivist Amid Federal Law Limits
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday
U.S. Announces Additional $6 Million in Humanitarian Aid to Cuba Amid Oil Sanctions and Fuel Shortages
UAE Plans Temporary Housing Complex for Displaced Palestinians in Southern Gaza
China Warns US Arms Sales to Taiwan Could Disrupt Trump’s Planned Visit
Norway Opens Corruption Probe Into Former PM and Nobel Committee Chair Thorbjoern Jagland Over Epstein Links
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
New York Legalizes Medical Aid in Dying for Terminally Ill Patients
Trump Signs “America First Arms Transfer Strategy” to Prioritize U.S. Weapons Sales
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



